Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Coriell scientist awarded grant to explore epigenetic drivers of breast cancer

Coriell scientist awarded grant to explore epigenetic drivers of breast cancer

Pharma’s take on the Pelosi drug-pricing bill: Fair warning or fearmongering?

Pharma’s take on the Pelosi drug-pricing bill: Fair warning or fearmongering?

Georgia State professor selected as National Academy of Inventors Fellow

Georgia State professor selected as National Academy of Inventors Fellow

ADDF announces new awards through its Diagnostics Accelerator initiative

ADDF announces new awards through its Diagnostics Accelerator initiative

Newly developed cell models can open up new avenues for ocular drug discovery

Newly developed cell models can open up new avenues for ocular drug discovery

LUNAC-led drug discovery project receives funding under Innovate UK’s Biomedical Catalyst program

LUNAC-led drug discovery project receives funding under Innovate UK’s Biomedical Catalyst program

Metrion and LifeArc extend neuroscience-focused ion channel drug discovery collaboration

Metrion and LifeArc extend neuroscience-focused ion channel drug discovery collaboration

Scientist earns prestigious award for research into cell suicide

Scientist earns prestigious award for research into cell suicide

IONTAS, Adaptate Biotherapeutics join forces to generate and optimize antibodies for novel cancer targets

IONTAS, Adaptate Biotherapeutics join forces to generate and optimize antibodies for novel cancer targets

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Consortium launches ambitious project to transform the treatment of pain

Consortium launches ambitious project to transform the treatment of pain

One Nucleus reveals finalists of annual BioNewsRound Award

One Nucleus reveals finalists of annual BioNewsRound Award

ICR scientists carry out first comprehensive assessment of chemical probe resources

ICR scientists carry out first comprehensive assessment of chemical probe resources

Oligomerix and Feinstein Institutes publish preclinical data of Alzheimer's disease treatment

Oligomerix and Feinstein Institutes publish preclinical data of Alzheimer's disease treatment

Better definition could lead to better diagnosis, treatment for rare diseases

Better definition could lead to better diagnosis, treatment for rare diseases

Novoheart collaborates with AstraZeneca to develop world’s first human heart-in-a-jar model of heart failure

Novoheart collaborates with AstraZeneca to develop world’s first human heart-in-a-jar model of heart failure

University of Sheffield receives Queen's Anniversary Prize for innovation in neuroscience

University of Sheffield receives Queen's Anniversary Prize for innovation in neuroscience

UTSA research aims to use sulfur to expedite new drug development

UTSA research aims to use sulfur to expedite new drug development

Coriell Institute for Medical Research wins $7.7 million NINDS contract

Coriell Institute for Medical Research wins $7.7 million NINDS contract

Researchers develop breakthrough in marine sponge cell culture

Researchers develop breakthrough in marine sponge cell culture